Transformation of the Nonprocessive Fast Skeletal Myosin II into a Processive Motor.


Journal

Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338

Informations de publication

Date de publication:
02 2019
Historique:
received: 16 10 2018
revised: 02 01 2019
pubmed: 19 1 2019
medline: 22 7 2020
entrez: 19 1 2019
Statut: ppublish

Résumé

Myosin family motors play diverse cellular roles. Precise insights into how the light chains contribute to the functional variabilities among myosin motors, however, remain unresolved. Here, it is demonstrated that the fast skeletal muscle myosin II isoform myosin heavy chain (MHC-IID) can be transformed into a processive motor, by simply replacing the native regulatory light chain MLC2f with the regulatory light chain variant MLC2v from the slow muscle myosin II. Single molecule kinetic analyses and optical trapping measurements of the hybrid motor reveal marked changes such as increased association rate of myosin toward adenosine triphosphate (ATP) and actin by more than twofold. The direct consequence of high adenosine diphosphate (ADP) affinity and increased actin rebinding is the altered overall actomyosin association time during the cross-bridge cycle. The data indicate that the MLC2v influences the duty ratio in the hybrid motor, suggestive of promoting interhead communication and enabling processive movement. This finding establishes that the regulatory light chain fine-tunes the motor's mechanical output that may have important implications under physiological conditions. Furthermore, the success of this approach paves the way to engineer motors from a known motor protein element to assemble highly specialized biohybrid machines for potential applications in nano-biomedicine and engineering.

Identifiants

pubmed: 30657637
doi: 10.1002/smll.201804313
doi:

Substances chimiques

Adenosine Triphosphate 8L70Q75FXE
Actomyosin 9013-26-7
Myosin Type II EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1804313

Informations de copyright

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Mamta Amrute-Nayak (M)

Institute of Molecular and Cell Physiology, Hannover Medical School, D-30625, Hannover, Germany.

Arnab Nayak (A)

Institute of Molecular and Cell Physiology, Hannover Medical School, D-30625, Hannover, Germany.

Walter Steffen (W)

Institute of Molecular and Cell Physiology, Hannover Medical School, D-30625, Hannover, Germany.

Georgios Tsiavaliaris (G)

Institute of Biophysical Chemistry, Hannover Medical School, D-30625, Hannover, Germany.

Tim Scholz (T)

Institute of Molecular and Cell Physiology, Hannover Medical School, D-30625, Hannover, Germany.

Bernhard Brenner (B)

Institute of Molecular and Cell Physiology, Hannover Medical School, D-30625, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH